Trial Profile
Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02, Which Active Ingredient is BPC-157, a Penta-deca-peptide From Gastric Source.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Bepecin (Primary)
- Indications Unspecified
- Focus Adverse reactions
- Sponsors PharmaCotherapia
- 28 Dec 2015 New trial record